Advertisement

Topics

WuXi STA Enables Ascletis to Receive NDA Approval from China FDA for Ganovo

04:04 EDT 14 Jun 2018 | Contract Pharma

Is first CDMO to support the approval of an innovative drug in China through the MAH pilot program

Original Article: WuXi STA Enables Ascletis to Receive NDA Approval from China FDA for Ganovo

NEXT ARTICLE

More From BioPortfolio on "WuXi STA Enables Ascletis to Receive NDA Approval from China FDA for Ganovo"

Advertisement
Quick Search
Advertisement
Advertisement

 

Relevant Topic

Pharmacy
Pharmacy is the science and technique of preparing as well as dispensing drugs and medicines. It is a health profession that links health sciences with chemical sciences and aims to ensure the safe and effective use of pharmaceutical drugs. The scope of...